Polyaspartamide-doxorubicin conjugate as potential prodrug for anticancer therapy.
Di Meo C, Cilurzo F, Licciardi M, Scialabba C, Sabia R, Paolino D, Capitani D, Fresta M, Giammona G, Villani C, Matricardi P.
Di Meo C, et al. Among authors: villani c.
Pharm Res. 2015 May;32(5):1557-69. doi: 10.1007/s11095-014-1557-2. Epub 2014 Oct 31.
Pharm Res. 2015.
PMID: 25366547